{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:10:47Z","timestamp":1750911047100,"version":"3.41.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T00:00:00Z","timestamp":1506124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00296-017-3820-4","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T09:09:15Z","timestamp":1506157755000},"page":"3-11","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tumor necrosis factor-associated periodic syndrome in adults"],"prefix":"10.1007","volume":"38","author":[{"given":"Sharika Gopakumar","family":"Menon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8923-7837","authenticated-orcid":false,"given":"Petros","family":"Efthimiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,23]]},"reference":[{"issue":"5","key":"3820_CR1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.semarthrit.2015.10.012","volume":"45","author":"Q Yao","year":"2016","unstructured":"Yao Q, Lacbawan F, Li J (2016) Adult autoinflammatory disease frequency and our diagnostic experience in an adult autoinflammatory clinic. Semin Arthritis Rheum 45(5):633\u2013637","journal-title":"Semin Arthritis Rheum"},{"key":"3820_CR2","first-page":"1","volume":"11","author":"D Rigante","year":"2016","unstructured":"Rigante D, Frediani B, Cantarini L (2016) A comprehensive overview of the hereditary periodic fever syndromes. Clin Rev Allergy Immunol 11:1\u20138","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"3820_CR3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0952-7915(00)00124-2","volume":"12","author":"J Galon","year":"2000","unstructured":"Galon J et al (2000) TNFRSF1A mutations and autoinflammatory syndromes. Curr Opin Immunol 12(4):479\u2013486","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"3820_CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/03009742.2015.1005663","volume":"44","author":"KKY Wong","year":"2015","unstructured":"Wong KKY et al (2015) Autosomal recessive transmission of TRAPS in a family with a novel TNFRSF1A mutation. Scand J Rheumatol 44(3):255\u2013256","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"3820_CR5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0300-2977(01)00149-8","volume":"59","author":"MF McDermott","year":"2001","unstructured":"McDermott MF, Frenkel J (2001) Hereditary periodic fever syndromes. Neth J Med 59(3):118\u2013125","journal-title":"Neth J Med"},{"issue":"11","key":"3820_CR6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1631\/jzus.2005.B1045","volume":"6","author":"E Gruys","year":"2005","unstructured":"Gruys E et al (2005) Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 6(11):1045\u20131056","journal-title":"J Zhejiang Univ Sci B"},{"issue":"9","key":"3820_CR7","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/art.11215","volume":"48","author":"E Aganna","year":"2003","unstructured":"Aganna E et al (2003) Heterogeneity among patients with tumor necrosis factor receptor\u2013associated periodic syndrome phenotypes. Arthritis Rheum 48(9):2632\u20132644","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3820_CR8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/humu.20720","volume":"29","author":"F Milhavet","year":"2008","unstructured":"Milhavet F et al (2008) The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 29(6):803\u2013808","journal-title":"Hum Mutat"},{"issue":"1","key":"3820_CR9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/nar\/gkg031","volume":"31","author":"Sarrauste C Menthiere de","year":"2003","unstructured":"de Menthiere Sarrauste C et al (2003) INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res 31(1):282\u2013285","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3820_CR10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/humu.20080","volume":"24","author":"I Touitou","year":"2004","unstructured":"Touitou I et al (2004) Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum Mutat 24(3):194\u2013198","journal-title":"Hum Mutat"},{"issue":"3","key":"3820_CR11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/s10165-010-0273-y","volume":"20","author":"P Lehmann","year":"2010","unstructured":"Lehmann P, Salzberger B et al (2010) Variable intrafamilial expressivity of the rare tumor necrosis factor-receptor associated periodic syndrome-associated mutation I170\u00a0N that affects the TNFR1A cleavage site. Mod Rheumatol 20(3):311\u2013315","journal-title":"Mod Rheumatol"},{"issue":"2","key":"3820_CR12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mpd.2003.15","volume":"142","author":"H Weyhreter","year":"2003","unstructured":"Weyhreter H et al (2003) A new mutation causing autosomal dominant periodic fever syndrome in a Danish family. J Pediatr 142(2):191\u2013193","journal-title":"J Pediatr"},{"issue":"1","key":"3820_CR13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12887-017-0856-2","volume":"17","author":"SM Radhakrishna","year":"2017","unstructured":"Radhakrishna SM, Grimm A, Broderick L (2017) Novel mutation identified in severe early-onset tumor necrosis factor receptor-associated periodic syndrome: a case report. BMC Pediatr 17(1):108","journal-title":"BMC Pediatr"},{"issue":"3","key":"3820_CR14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/art.21657","volume":"54","author":"A D\u2019Osualdo","year":"2006","unstructured":"D\u2019Osualdo A et al (2006) Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor\u2013induced apoptosis: pathogenetic and clinical implications. Arthritis Rheum 54(3):998\u20131008","journal-title":"Arthritis Rheum"},{"issue":"12","key":"3820_CR15","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1093\/rheumatology\/keq227","volume":"49","author":"KR Quimby","year":"2010","unstructured":"Quimby KR et al (2010) Tumor necrosis factor receptor-associated periodic syndrome P46L and bilateral amputation in diabetes. Rheumatology 49(12):2454\u20132455","journal-title":"Rheumatology"},{"issue":"1","key":"3820_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2567.2004.01942.x","volume":"113","author":"I Todd","year":"2004","unstructured":"Todd I et al (2004) Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour. Immunology 113(1):65\u201379","journal-title":"Immunology"},{"issue":"1","key":"3820_CR17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/art.24147","volume":"60","author":"SL Rebelo","year":"2009","unstructured":"Rebelo SL et al (2009) Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line. Arthritis Rheum 60(1):269\u2013280","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3820_CR18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/art.24145","volume":"60","author":"JG Ryan","year":"2009","unstructured":"Ryan JG, Aksentijevich I (2009) Tumor necrosis factor receptor\u2013associated periodic syndrome: toward a molecular understanding of the systemic autoinflammatory diseases. Arthritis Rheum 60(1):8\u201311","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3820_CR19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20102049","volume":"208","author":"AC Bulua","year":"2011","unstructured":"Bulua AC et al (2011) Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med 208(3):519\u2013533","journal-title":"J Exp Med"},{"issue":"4","key":"3820_CR20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.20955","volume":"52","author":"S Siebert","year":"2005","unstructured":"Siebert S et al (2005) Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis Rheum 52(4):1287\u20131292","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3820_CR21","doi-asserted-by":"crossref","first-page":"e71477","DOI":"10.1371\/journal.pone.0071477","volume":"8","author":"S \u00c1lvarez","year":"2013","unstructured":"\u00c1lvarez S, Mu\u00f1oz-Fern\u00e1ndez M\u00c1 (2013) TNF-\u0391 may mediate inflammasome activation in the absence of bacterial infection in more than one way. PLoS ONE 8(8):e71477","journal-title":"PLoS ONE"},{"issue":"10","key":"3820_CR22","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/eji.201545769","volume":"45","author":"LC Fairclough","year":"2015","unstructured":"Fairclough LC et al (2015) Tumour necrosis factor receptor I blockade shows that TNF-dependent and TNF-independent mechanisms synergise in TNF receptor associated periodic syndrome. Eur J Immunol 45(10):2937\u20132944","journal-title":"Eur J Immunol"},{"issue":"9","key":"3820_CR23","doi-asserted-by":"crossref","first-page":"e73443","DOI":"10.1371\/journal.pone.0073443","volume":"8","author":"OM Lucherini","year":"2013","unstructured":"Lucherini OM et al (2013) First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). PLoS ONE 8(9):e73443","journal-title":"PLoS ONE"},{"issue":"2","key":"3820_CR24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1086\/321976","volume":"69","author":"I Aksentijevich","year":"2001","unstructured":"Aksentijevich I et al (2001) The tumor-necrosis-factor receptor associated periodic syndrome: new mutations in TNFRSF1A ancestral origins, genotype-phenotype studies, and evidence for further Genetic heterogeneity of periodic fevers. Am J Hum Genet 69(2):301\u2013314","journal-title":"Am J Hum Genet"},{"issue":"5","key":"3820_CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","volume":"81","author":"KM Hull","year":"2002","unstructured":"Hull KM et al (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine 81(5):349\u2013368","journal-title":"Medicine"},{"issue":"1","key":"3820_CR26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.ejhg.5200573","volume":"9","author":"E Aganna","year":"2001","unstructured":"Aganna E et al (2001) Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance. Eur J Hum Genet 9(1):63\u201366","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"3820_CR27","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/rheumatology\/kep140","volume":"48","author":"E Lainka","year":"2009","unstructured":"Lainka E et al (2009) Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics. Rheumatology 48(8):987\u2013991","journal-title":"Rheumatology"},{"issue":"9","key":"3820_CR28","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/ard.2005.048611","volume":"65","author":"N Ravet","year":"2006","unstructured":"Ravet N et al (2006) Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis 65(9):1158\u20131162","journal-title":"Ann Rheum Dis"},{"key":"3820_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fimmu.2017.00299","volume":"8","author":"E Ruiz-Ortiz","year":"2017","unstructured":"Ruiz-Ortiz E et al (2017) Disease phenotype and outcome depending on the age at disease onset in patients carrying the R92Q low-penetrance variant in TNFRSF1A gene. Front Immunol 8:299","journal-title":"Front Immunol"},{"issue":"8","key":"3820_CR30","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/art.10429","volume":"46","author":"C Dod\u00e9","year":"2002","unstructured":"Dod\u00e9 C et al (2002) The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor\u2013associated periodic syndrome. Arthritis Rheum 46(8):2181\u20132188","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3820_CR31","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.semarthrit.2013.12.002","volume":"43","author":"L Cantarini","year":"2014","unstructured":"Cantarini L et al (2014) The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up. Semin Arthritis Rheum 43(6):818\u2013823","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"3820_CR32","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/art.30237","volume":"63","author":"MA Pelagatti","year":"2011","unstructured":"Pelagatti MA et al (2011) Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. Arthritis Rheum 63(4):1141\u20131150","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3820_CR33","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/ard.2007.079376","volume":"67","author":"S Stojanov","year":"2008","unstructured":"Stojanov S et al (2008) Clinical and functional characterisation of a novel TNFRSF1A c.605T\u00a0>\u00a0A\/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Ann Rheum Dis 67(9):1292\u20131298","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3820_CR34","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/1346-8138.12689","volume":"41","author":"S Ohmori","year":"2014","unstructured":"Ohmori S, Hino R, Nakamura M (2014) Inflammatory response to heparinoid and heparin in a patient with tumor necrosis factor receptor-associated periodic syndrome: the second case with a T61I mutation in the TNFRSF1A gene. J Dermatol 41(12):1112\u20131113","journal-title":"J Dermatol"},{"key":"3820_CR35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fimmu.2013.00096","volume":"4","author":"L Cantarini","year":"2013","unstructured":"Cantarini L, Lucherini OM, Rigante D (2013) Caution should be used in the recognition of adult-onset autoinflammatory disorders: facts or fiction? Front Immunol 4:96","journal-title":"Front Immunol"},{"issue":"7","key":"3820_CR36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ad.2012.11.008","volume":"104","author":"L Aguado-Gil","year":"2013","unstructured":"Aguado-Gil L, Irarrazaval-Armendariz I, Pretel-Irazabal M (2013) Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome. Actas Dermosifiliogr 104(7):617\u2013622","journal-title":"Actas Dermosifiliogr"},{"issue":"5","key":"3820_CR37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jbspin.2009.08.002","volume":"76","author":"Y Schoindre","year":"2009","unstructured":"Schoindre Y et al (2009) TNF receptor-associated periodic syndrome (TRAPS): a new cause of joint destruction? Joint Bone Spine 76(5):567\u2013569","journal-title":"Joint Bone Spine"},{"issue":"12","key":"3820_CR38","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/annrheumdis-2013-204184","volume":"73","author":"HJ Lachmann","year":"2014","unstructured":"Lachmann HJ et al (2014) The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry. Ann Rheum Dis 73(12):2160\u20132167","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3820_CR39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.autrev.2015.08.008","volume":"15","author":"J Hern\u00e1ndez-Rodr\u00edguez","year":"2016","unstructured":"Hern\u00e1ndez-Rodr\u00edguez J et al (2016) Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center. Autoimmun Rev 15(1):9\u201315","journal-title":"Autoimmun Rev"},{"issue":"5","key":"3820_CR40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s10067-012-1942-3","volume":"31","author":"C Vergara","year":"2012","unstructured":"Vergara C et al (2012) Clinical and genetic features of hereditary periodic fever syndromes in Hispanic patients: the Chilean experience. Clin Rheumatol 31(5):829\u2013834","journal-title":"Clin Rheumatol"},{"issue":"7","key":"3820_CR41","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10067-015-2920-3","volume":"34","author":"V Bascherini","year":"2015","unstructured":"Bascherini V et al (2015) The protean ocular involvement in monogenic autoinflammatory diseases: state of the art. Clin Rheumatol 34(7):1171\u20131180","journal-title":"Clin Rheumatol"},{"issue":"7","key":"3820_CR42","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/PEC.0b013e318298df8b","volume":"29","author":"A Koyfman","year":"2013","unstructured":"Koyfman A et al (2013) A taste of periodic fever syndromes. Pediatr Emerg Care 29(7):842\u2013851","journal-title":"Pediatr Emerg Care"},{"key":"3820_CR43","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fimmu.2017.00344","volume":"8","author":"D Martorana","year":"2017","unstructured":"Martorana D et al (2017) Monogenic autoinflammatory diseases with Mendelian inheritance: genes, mutations, and genotype\/phenotype correlations. Front Immunol 8:344","journal-title":"Front Immunol"},{"issue":"4","key":"3820_CR44","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.semarthrit.2011.07.008","volume":"41","author":"Q Yao","year":"2012","unstructured":"Yao Q et al (2012) Tumor necrosis factor receptor associated periodic fever syndrome with photographic evidence of various skin disease and unusual phenotypes: case report and literature review. Semin Arthritis Rheum 41(4):611\u2013617","journal-title":"Semin Arthritis Rheum"},{"key":"3820_CR45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1155\/2013\/513782","volume":"2013","author":"F Caso","year":"2013","unstructured":"Caso F et al (2013) Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol 2013:15","journal-title":"Int J Rheumatol"},{"issue":"1","key":"3820_CR46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/abd1806-4841.20175208","volume":"92","author":"A Moreira","year":"2017","unstructured":"Moreira A et al (2017) Skin symptoms as diagnostic clue for autoinflammatory diseases. Anais Brasileiros de Dermatologia 92(1):72\u201380","journal-title":"Anais Brasileiros de Dermatologia"},{"issue":"1","key":"3820_CR47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/derm.2.1.12387","volume":"2","author":"R Schmaltz","year":"2010","unstructured":"Schmaltz R, Vogt T, Reichrath J (2010) Skin manifestations in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Dermatoendocrinol 2(1):26\u201329","journal-title":"Dermatoendocrinol"},{"issue":"12","key":"3820_CR48","first-page":"1487","volume":"136","author":"JR Toro","year":"2000","unstructured":"Toro JR et al (2000) Tumor necrosis factor receptor\u2013associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 136(12):1487\u20131494","journal-title":"Arch Dermatol"},{"issue":"6","key":"3820_CR49","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00403-011-1134-z","volume":"303","author":"D Rigante","year":"2011","unstructured":"Rigante D, Cantarini L (2011) Monogenic autoinflammatory syndromes at a dermatological level. Arch Dermatol Res 303(6):375\u2013380","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"3820_CR50","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/art.10448","volume":"46","author":"KM Hull","year":"2002","unstructured":"Hull KM et al (2002) Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction. Arthritis Rheum 46(8):2189\u20132194","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3820_CR51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00392-012-0422-8","volume":"101","author":"L Cantarini","year":"2012","unstructured":"Cantarini L et al (2012) Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol 101(7):525\u2013531","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"3820_CR52","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.ejim.2008.07.028","volume":"20","author":"F Roubille","year":"2009","unstructured":"Roubille F et al (2009) Acute myocarditis and tumor necrosis factor receptor-associated periodic (TRAP) syndrome: first case described and discussion. Eur J Intern Med 20(2):e25\u2013e26","journal-title":"Eur J Intern Med"},{"issue":"1","key":"3820_CR53","first-page":"175","volume":"32","author":"S Trost","year":"2005","unstructured":"Trost S, Ros\u00e9 CD (2005) Myocarditis and sacroiliitis: 2 previously unrecognized manifestations of tumor necrosis factor receptor associated periodic syndrome. J Rheumatol 32(1):175\u2013177","journal-title":"J Rheumatol"},{"issue":"10","key":"3820_CR54","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00115-005-1906-9","volume":"76","author":"P G\u00fcnther","year":"2005","unstructured":"G\u00fcnther P et al (2005) TNF-Rezeptor-assoziiertes periodisches Syndrom. Der Nervenarzt 76(10):1263\u20131266","journal-title":"Der Nervenarzt"},{"issue":"10","key":"3820_CR55","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/ard.2003.016006","volume":"63","author":"K Minden","year":"2004","unstructured":"Minden K et al (2004) Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement. Ann Rheum Dis 63(10):1356\u20131357","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3820_CR56","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/ndt\/gfk098","volume":"21","author":"JG Rudofsky","year":"2006","unstructured":"Rudofsky JG et al (2006) A nephrotic patient with tumour necrosis factor receptor-associated periodic syndrome, IgA nephropathy and CNS involvement. Nephrol Dial Transplant 21(4):1109\u20131112","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"3820_CR57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1469-8749.2009.03336.x","volume":"51","author":"GAM Sanchez","year":"2009","unstructured":"Sanchez GAM, Hashkes PJ (2009) Neurological manifestations of the Mendelian-inherited autoinflammatory syndromes. Dev Med Child Neurol 51(6):420\u2013428","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"3820_CR58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3899\/jrheum.120729","volume":"40","author":"J Havla","year":"2013","unstructured":"Havla J et al (2013) Symptoms related to tumor necrosis factor receptor 1-associated periodic syndrome, multiple sclerosis, and severe rheumatoid arthritis in patients carrying the TNF receptor superfamily 1A D12E\/p.Asp41Glu mutation. J Rheumatol 40(3):261\u2013264","journal-title":"J Rheumatol"},{"issue":"8","key":"3820_CR59","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.22795","volume":"56","author":"T Kumpfel","year":"2007","unstructured":"Kumpfel T et al (2007) Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation. Arthritis Rheum 56(8):2774\u20132783","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3820_CR60","first-page":"94","volume":"28","author":"FT Saulsbury","year":"2010","unstructured":"Saulsbury FT, Remmers EF, Aksentijevich I (2010) A novel mutation in TNFRSF1A associated with overlapping features of tumor necrosis factor receptor-associated periodic syndrome and hyper-IgD syndrome. Clin Exp Rheumatol 28(1):94\u201396","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"3820_CR61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/ard.2010.132613","volume":"70","author":"M Piram","year":"2011","unstructured":"Piram M et al (2011) A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the auto-inflammatory diseases activity index (AIDAI) consensus conference. Ann Rheum Dis 70(2):309\u2013314","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3820_CR62","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1136\/annrheumdis-2013-203666","volume":"73","author":"M Piram","year":"2014","unstructured":"Piram M et al (2014) Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes. Ann Rheum Dis 73(12):2168\u20132173","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3820_CR63","first-page":"405","volume":"28","author":"L Cantarini","year":"2010","unstructured":"Cantarini L et al (2010) Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. Clin Exp Rheumatol 28(3):405\u2013407","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"3820_CR64","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10741-012-9335-x","volume":"18","author":"PM Seferovic","year":"2013","unstructured":"Seferovic PM et al (2013) Pericardial syndromes: an update after the ESC guidelines 2004. Heart Fail Rev 18(3):255\u2013266","journal-title":"Heart Fail Rev"},{"issue":"3","key":"3820_CR65","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/BOR.0000000000000059","volume":"26","author":"NM Ter Haar","year":"2014","unstructured":"Ter Haar NM, Frenkel J (2014) Treatment of hereditary autoinflammatory diseases. Curr Opin Rheumatol 26(3):252\u2013258","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"3820_CR66","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jmii.2012.07.003","volume":"47","author":"YJ Chen","year":"2014","unstructured":"Chen YJ et al (2014) Recurrent abdominal pain as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in an Asian girl: a case report and review of the literature. J Microbiol Immunol Infect 47(6):550\u2013554","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"3820_CR67","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.33416","volume":"64","author":"AC Bulua","year":"2012","unstructured":"Bulua AC et al (2012) Efficacy of etanercept in the tumor necrosis factor receptor\u2013associated periodic syndrome: a prospective, open-label, dose-escalation study. Arthritis Rheum 64(3):908\u2013913","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3820_CR68","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00296-009-0937-0","volume":"30","author":"H Morbach","year":"2009","unstructured":"Morbach H et al (2009) Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment. Rheumatol Int 30(2):207\u2013212","journal-title":"Rheumatol Int"},{"key":"3820_CR69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1155\/2013\/939847","volume":"2013","author":"A Vitale","year":"2013","unstructured":"Vitale A et al (2013) Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm 2013:16","journal-title":"Mediators Inflamm"},{"issue":"4","key":"3820_CR70","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/acr.23120","volume":"69","author":"S Ozen","year":"2017","unstructured":"Ozen S et al (2017) International retrospective chart review of treatment patterns in severe familial mediterranean fever, tumor necrosis factor receptor-associated periodic syndrome, and mevalonate kinase deficiency\/hyperimmunoglobulinemia D syndrome. Arthritis Care Res 69(4):578\u2013586","journal-title":"Arthritis Care Res"},{"issue":"11","key":"3820_CR71","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/rheumatology\/keh357","volume":"43","author":"E Drewe","year":"2004","unstructured":"Drewe E et al (2004) Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology 43(11):1405\u20131408","journal-title":"Rheumatology"},{"issue":"9","key":"3820_CR72","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/ard.2010.144279","volume":"70","author":"N Quillinan","year":"2011","unstructured":"Quillinan N et al (2011) Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome. Ann Rheum Dis 70(9):1692\u20131693","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3820_CR73","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/rheumatology\/kel298","volume":"46","author":"S Jacobelli","year":"2007","unstructured":"Jacobelli S et al (2007) Failure of anti-TNF therapy in TNF Receptor 1-associated periodic syndrome (TRAPS). Rheumatology 46(7):1211\u20131212","journal-title":"Rheumatology"},{"issue":"2","key":"3820_CR74","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.24294","volume":"60","author":"B Nedjai","year":"2009","unstructured":"Nedjai B, Hitman GA, Quillinan N et al (2009) Proinflammatory action of the anti-inflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 60(2):619\u2013625","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3820_CR75","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.3899\/jrheum.091094","volume":"37","author":"M Krelenbaum","year":"2010","unstructured":"Krelenbaum M, Chaiton A (2010) Successful treatment with infliximab of a patient with tumor necrosis factor-associated periodic syndrome (TRAPS) who Failed to respond to etanercept. J Rheumatol 37(8):1780\u20131782","journal-title":"J Rheumatol"},{"issue":"9","key":"3820_CR76","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/rheumatology\/kev111","volume":"54","author":"C Grimwood","year":"2015","unstructured":"Grimwood C et al (2015) On-demand treatment with anakinra: a treatment option for selected TRAPS patients. Rheumatology 54(9):1749\u20131751","journal-title":"Rheumatology"},{"key":"3820_CR77","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s10067-017-3688-4","volume":"36","author":"S Gentileschi","year":"2017","unstructured":"Gentileschi S et al (2017) Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature. Clin Rheumatol 36:1687\u20131690","journal-title":"Clin Rheumatol"},{"key":"3820_CR78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13075-015-0604-7","volume":"17","author":"E Greco","year":"2015","unstructured":"Greco E et al (2015) The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-kappaB pathway. Arthritis Res Ther 17:93","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"3820_CR79","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00246-012-0532-0","volume":"34","author":"A Scardapane","year":"2013","unstructured":"Scardapane A et al (2013) Efficacy of an interleukin-1\u03b2 receptor antagonist (anakinra) in idiopathic recurrent pericarditis. Pediatr Cardiol 34(8):1989\u20131991","journal-title":"Pediatr Cardiol"},{"key":"3820_CR80","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/1756-185X.13029","volume":"20","author":"D Camprubi","year":"2016","unstructured":"Camprubi D et al (2016) Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant. Int J Rheum Dis 20:510\u2013514","journal-title":"Int J Rheum Dis"},{"key":"3820_CR81","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1136\/annrheumdis-2014-205990","volume":"73","author":"G Lazaros","year":"2014","unstructured":"Lazaros G et al (2014) Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases. Ann Rheum Dis 73:2215\u20132217","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3820_CR82","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/annrheumdis-2016-209335","volume":"76","author":"R Torene","year":"2017","unstructured":"Torene R et al (2017) Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome. Ann Rheum Dis 76(1):303\u2013309","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3820_CR83","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/annrheumdis-2015-209031","volume":"76","author":"M Gattorno","year":"2017","unstructured":"Gattorno M et al (2017) Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study. Ann Rheum Dis 76(1):173\u2013178","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3820_CR84","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10067-014-2556-8","volume":"34","author":"G Lopalco","year":"2015","unstructured":"Lopalco G et al (2015) Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate. Clin Rheumatol 34(4):807\u2013809","journal-title":"Clin Rheumatol"},{"issue":"12","key":"3820_CR85","doi-asserted-by":"crossref","first-page":"907","DOI":"10.7326\/0003-4819-156-12-201206190-00027","volume":"156","author":"M Brizi","year":"2012","unstructured":"Brizi M et al (2012) Successful treatment of tumor necrosis factor receptor\u2013associated periodic syndrome with canakinumab. Ann Intern Med 156(12):907\u2013908","journal-title":"Ann Intern Med"},{"key":"3820_CR86","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/annrheumdis-2016-eular.3881","volume":"75","author":"F Benedetti De","year":"2016","unstructured":"De Benedetti F, Anton J, Gattorno M et al (2016) FRI0488\u2005A phase Iii pivotal umbrella trial of canakinumab in patients with autoinflammatory periodic fever syndromes (colchicine resistant FMF, HIDS\/MKD and TRAPS). Ann Rheum Dis 75:615\u2013616","journal-title":"Ann Rheum Dis"},{"key":"3820_CR87","first-page":"5","volume":"167","author":"T Kishimoto","year":"1992","unstructured":"Kishimoto T et al (1992) The molecular biology of interleukin 6 and its receptor. Ciba Found Symp 167:5\u201316 (discussion 16\u201323)","journal-title":"Ciba Found Symp"},{"issue":"1","key":"3820_CR88","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.berh.2012.01.001","volume":"26","author":"L Kaly","year":"2013","unstructured":"Kaly L, Rosner I, Tocilizumab (2013) A novel therapy for non-organ-specific autoimmune diseases. Best Pract Res Clin Rheumatol 26(1):157\u2013165","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"3820_CR89","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.30215","volume":"63","author":"PM Vaitla","year":"2011","unstructured":"Vaitla PM et al (2011) Role of interleukin-6 in a patient with tumor necrosis factor receptor\u2013associated periodic syndrome: assessment of outcomes following treatment with the anti\u2013interleukin-6 receptor monoclonal antibody tocilizumab. Arthritis Rheum 63(4):1151\u20131155","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3820_CR90","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00296-015-3305-2","volume":"35","author":"F Torre La","year":"2015","unstructured":"La Torre F et al (2015) Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Rheumatol Int 35(11):1943\u20131947","journal-title":"Rheumatol Int"},{"issue":"1","key":"3820_CR91","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5152\/eurjrheumatol.2014.14053","volume":"2","author":"N Akasbi","year":"2015","unstructured":"Akasbi N, Soyfoo MS (2015) Successful treatment of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) with tocilizumab: a case report. Eur J Rheumatol 2(1):35\u201336","journal-title":"Eur J Rheumatol"},{"issue":"16","key":"3820_CR92","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2169\/internalmedicine.54.3371","volume":"54","author":"T Hosoya","year":"2015","unstructured":"Hosoya T et al (2015) A case presenting with the clinical characteristics of tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) without TNFRSF1A mutations successfully treated with tocilizumab. Intern Med 54(16):2069\u20132072","journal-title":"Intern Med"},{"issue":"1","key":"3820_CR93","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.autrev.2012.07.016","volume":"12","author":"L Obici","year":"2012","unstructured":"Obici L, Merlini G (2012) Amyloidosis in autoinflammatory syndromes. Autoimmun Rev 12(1):14\u201317","journal-title":"Autoimmun Rev"},{"issue":"4","key":"3820_CR94","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/art.37827","volume":"65","author":"T Lane","year":"2013","unstructured":"Lane T et al (2013) AA amyloidosis complicating the hereditary periodic fever syndromes. Arthritis Rheum 65(4):1116\u20131121","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3820_CR95","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10238-005-0071-6","volume":"5","author":"JCH Hilst van der","year":"2005","unstructured":"van der Hilst JCH, Simon A, Drenth JPH (2005) Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 5(3):87\u201398","journal-title":"Clin Exp Med"},{"issue":"1","key":"3820_CR96","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.transproceed.2015.11.006","volume":"48","author":"N Rodziewicz","year":"2016","unstructured":"Rodziewicz N et al (2016) Kidney transplant in a patient with tumor necrosis factor receptor-1 syndrome (TRAPS): case report and review of the literature. Transpl Proc 48(1):265\u2013266","journal-title":"Transpl Proc"},{"issue":"10","key":"3820_CR97","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1002\/art.23887","volume":"58","author":"J Harambat","year":"2008","unstructured":"Harambat J et al (2008) First report of rapidly progressive glomerulonephritis in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 58(10):3275\u20133276","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3820_CR98","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s10067-015-2923-0","volume":"34","author":"D Rigante","year":"2015","unstructured":"Rigante D et al (2015) Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol 34(8):1333\u20131339","journal-title":"Clin Rheumatol"},{"issue":"3 Suppl 77","key":"3820_CR99","first-page":"99","volume":"31","author":"G Horneff","year":"2013","unstructured":"Horneff G et al (2013) Macrophage activation syndrome as the initial manifestation of tumour necrosis factor receptor 1-associated periodic syndrome (TRAPS). Clin Exp Rheumatol 31(3 Suppl 77):99\u2013102","journal-title":"Clin Exp Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3820-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3820-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3820-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T21:41:45Z","timestamp":1750887705000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3820-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,23]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3820"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3820-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2017,9,23]]}}}